115
Views
21
CrossRef citations to date
0
Altmetric
Review

Defining the genetic aetiology of monogenic diabetes can improve treatment

&
Pages 1759-1767 | Published online: 23 Aug 2006

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Christina L Aquilante. (2010) Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms. Expert Review of Cardiovascular Therapy 8:3, pages 359-372.
Read now

Articles from other publishers (20)

Liu Yang, Chen Huang, Min Zhao, Priscilla M. Y. Lee, Cheng Zhang, Yongfu Yu, Bo Xi & Jiong Li. (2023) Maternal hypertensive disorders during pregnancy and the risk of offspring diabetes mellitus in childhood, adolescence, and early adulthood: a nationwide population-based cohort study. BMC Medicine 21:1.
Crossref
Yichen Dai, Rodrigo Pracana & Peter W. H. Holland. (2020) Divergent genes in gerbils: prevalence, relation to GC-biased substitution, and phenotypic relevance. BMC Evolutionary Biology 20:1.
Crossref
Pernille Svalastoga, Åsta Sulen, Jarle R. Fehn, Stein M. Aukland, Henrik Irgens, Eivind Sirnes, Silje K.E. Fevang, Eivind Valen, Irene B. Elgen & Pål R. Njølstad. (2020) Intellectual Disability in KATP Channel Neonatal Diabetes. Diabetes Care 43:3, pages 526-533.
Crossref
Nina ØyenLars J. DiazElisabeth LeirgulHeather A. BoydJames PriestElisabeth R. MathiesenThomas QuertermousJan WohlfahrtMads Melbye. (2016) Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease. Circulation 133:23, pages 2243-2253.
Crossref
Peter Kovacs & Ewan Pearson. 2016. The Genetics of Type 2 Diabetes and Related Traits. The Genetics of Type 2 Diabetes and Related Traits 483 497 .
Angeli M. van der Zwaag, Stephanie S. Weinreich, Astrid R. Bosma, Tessel Rigter, Monique Losekoot, Lidewij Henneman & Martina C. Cornel. (2015) Current and Best Practices of Genetic Testing for Maturity Onset Diabetes of the Young: Views of Professional Experts. Public Health Genomics 18:1, pages 52-59.
Crossref
Anke Tönjes & Peter Kovacs. (2013) SGLT2 : a potential target for the pharmacogenetics of Type 2 diabetes? . Pharmacogenomics 14:7, pages 825-833.
Crossref
Christina L. Aquilante & Y.W. Francis Lam. 2013. Pharmacogenomics. Pharmacogenomics 247 271 .
Gaia Chiara Mannino & Giorgio Sesti. (2012) Individualized Therapy for Type 2 Diabetes. Molecular Diagnosis & Therapy 16:5, pages 285-302.
Crossref
A. M. Steele, B. M. Shields, M. Shepherd, S. Ellard, A. T. Hattersley & E. R. Pearson. (2010) Increased all‐cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene. Diabetic Medicine 27:2, pages 157-161.
Crossref
Louis H. Philipson, Rinki Murphy, Sian Ellard, Andrew T. Hattersley, Julie Støy, Siri A. Greeley, Graeme I. Bell & Kenneth S. Polonsky. 2010. Genetic Diagnosis of Endocrine Disorders. Genetic Diagnosis of Endocrine Disorders 17 25 .
A. L. Gloyn. (2009) RD Lawrence Lecture 2009 Old genes, new tricks: learning about blood glucose regulation from naturally occurring genetic variation in humans. Diabetic Medicine 26:11, pages 1083-1089.
Crossref
Kara K. Osbak, Kevin Colclough, Cecile Saint-Martin, Nicola L. Beer, Christine Bellanné-Chantelot, Sian Ellard & Anna L. Gloyn. (2009) Update on mutations in glucokinase ( GCK ), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia . Human Mutation 30:11, pages 1512-1526.
Crossref
Daniela GašperíkováNicolas D. TribbleJuraj StaníkMiroslava HučkováNadežda MišovicováMartijn van de BuntLucia ValentínováBeryl A. BarrowL'ubomir BarákRadoslav DobránskyEva BereczkováJozef MichálekKate WicksKevin ColcloughJulian C. KnightSian EllardIwar KlimešAnna L. Gloyn. (2009) Identification of a Novel β-Cell Glucokinase ( GCK ) Promoter Mutation (−71G>C) That Modulates GCK Gene Expression Through Loss of Allele-Specific Sp1 Binding Causing Mild Fasting Hyperglycemia in Humans . Diabetes 58:8, pages 1929-1935.
Crossref
Thomas Waterfield & Anna L Gloyn. (2008) Monogenic β-cell dysfunction in children: clinical phenotypes, genetic etiology and mutational pathways. Pediatric Health 2:4, pages 517-532.
Crossref
A. L. Gloyn & M. I. McCarthy. (2008) Genetics: how the UKPDS contributed to determining the genetic landscape of Type 2 diabetes. Diabetic Medicine 25, pages 35-40.
Crossref
Lucimary C. Gurgel & Regina S. Moisés. (2008) Diabetes melito neonatal. Arquivos Brasileiros de Endocrinologia & Metabologia 52:2, pages 181-187.
Crossref
Jonathan M. LockeLorna W. Harries. (2008) RNA Processing and mRNA Surveillance in Monogenic Diabetes. Gene Regulation and Systems Biology 2, pages GRSB.S782.
Crossref
S. Ellard, K. Thomas, E. L. Edghill, M. Owens, L. Ambye, J. Cropper, J. Little, M. Strachan, A. Stride, B. Ersoy, H. Eiberg, O. Pedersen, M. H. Shepherd, T. Hansen, L. W. Harries & A. T. Hattersley. (2007) Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia 50:11, pages 2313-2317.
Crossref
J. A. L. Minton, M. van de Bunt, C. Boustred, K. Hussain, A. T. Hattersley, S. Ellard & A. L. Gloyn. (2007) Mutations in HHEX are not a common cause of monogenic forms of beta cell dysfunction. Diabetologia 50:9, pages 2019-2022.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.